(FSMD) Fidelity Small-Mid Factor - Overview
Etf: Stocks, Small-Cap, Mid-Cap, Multifactor, Index
Dividends
| Dividend Yield | 1.40% |
| Yield on Cost 5y | 2.00% |
| Yield CAGR 5y | 8.69% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.3% |
| Relative Tail Risk | -4.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -2.36 |
| Character TTM | |
|---|---|
| Beta | 0.922 |
| Beta Downside | 0.911 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.16% |
| CAGR/Max DD | 0.63 |
Description: FSMD Fidelity Small-Mid Factor January 16, 2026
FSMD is a U.S.-based ETF that tracks the Fidelity Small-Mid Multifactor Index, committing at least 80% of its assets to small- and mid-cap equities chosen for attractive valuations, high quality, positive momentum, and lower volatility versus the broader market.
According to the most recent fund factsheet (as of 2024-Q4), FSMD carries an expense ratio of 0.29%, manages roughly $2 billion in assets, and has a weighted-average market capitalization of about $5 billion. Its sector tilt is roughly 30% technology and 20% health-care-areas driven by ongoing digital transformation and demographic aging, both of which historically boost small-mid cap growth.
Small-mid cap performance is especially sensitive to U.S. real-GDP growth and the Federal Reserve’s interest-rate stance; therefore, tracking real-GDP trends and the 2-year/10-year yield-curve spread can provide early signals of upside or downside for the fund.
For a deeper quantitative view, you might explore ValueRay’s factor-analytics tools to see how FSMD’s factor exposures compare to peers.
What is the price of FSMD shares?
Over the past week, the price has changed by +3.96%, over one month by +4.51%, over three months by +11.35% and over the past year by +12.51%.
Is FSMD a buy, sell or hold?
What are the forecasts/targets for the FSMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 53.4 | 12.4% |
FSMD Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.03b USD (2.03b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.03b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.03b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.31% (E(2.03b)/V(2.03b) * Re(9.31%) + (debt-free company))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)